Literature DB >> 2323815

Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens.

T Chardès1, I Bourguin, M N Mevelec, J F Dubremetz, D Bout.   

Abstract

Toxoplasma gondii-specific antibody responses in serum, intestinal secretions, and milk were identified with an enzyme-linked immunosorbent assay following a single oral infection of mice with strain 76K cysts of T. gondii. Immunoglobulin A (IgA) production began during week 2 of infection in serum and milk and during week 3 of infection in intestinal secretions and persisted in all three throughout the experiment (17 weeks). IgG but not IgM antibodies were detected in intestinal secretions later in the infection. Serum and milk IgG and IgM production began at the same time after infection as did the IgA response. In Western blotting (immunoblotting), intestinal IgA antibodies were shown to react with antigens comigrating with the T. gondii proteins p22, p23, p30, and p43, the 28-kilodalton antigen, and the 55- and 60-kilodalton rhoptry proteins, as recognized by specific monoclonal antibodies. Milk IgA antibodies reacted with antigens comigrating with p30 and p43. Most of the antigens recognized by IgA antibodies were also detected by IgG antibodies. IgA antibodies from all three biological samples detected the same major T. gondii antigens; thus, there was apparently no specific antibody production unique to one locality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323815      PMCID: PMC258615          DOI: 10.1128/iai.58.5.1240-1246.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

2.  [Specific serum IgAs in the diagnosis of toxoplasmosis].

Authors:  Y Le Fichoux; P Marty; H Chan
Journal:  Ann Pediatr (Paris)       Date:  1987-05

3.  Use of enzyme-linked immunosorbent assays (ELISA) for detection of monoclonal antibodies: experience with antigens of Toxoplasma gondii.

Authors:  Y Naot; J S Remington
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.

Authors:  C O Elson; W Ealding; J Lefkowitz
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

5.  Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.

Authors:  N F Pierce; W C Cray; J B Sacci; J P Craig; R Germanier; E Fürer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

7.  Protection against cholera in breast-fed children by antibodies in breast milk.

Authors:  R I Glass; A M Svennerholm; B J Stoll; M R Khan; K M Hossain; M I Huq; J Holmgren
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

8.  Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection.

Authors:  P Partanen; H J Turunen; R T Paasivuo; P O Leinikki
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

9.  Recognition of Toxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection.

Authors:  A Decoster; F Darcy; A Capron
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

10.  Effect of antigen form on local immunoglobulin A memory response of intestinal secretions to Shigella flexneri.

Authors:  D F Keren; R A McDonald; P J Scott; A M Rosner; E Strubel
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  32 in total

1.  Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.

Authors:  F Velge-Roussel; P Marcelo; A C Lepage; D Buzoni-Gatel; D T Bout
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii.

Authors:  R Saavedra; M A Becerril; C Dubeaux; R Lippens; M J De Vos; P Hérion; A Bollen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Replication and distribution of Toxoplasma gondii in the small intestine after oral infection with tissue cysts.

Authors:  Beth Gregg; Betsy C Taylor; Beena John; Elia D Tait-Wojno; Natasha M Girgis; Natalie Miller; Sagie Wagage; David S Roos; Christopher A Hunter
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

5.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

6.  Antigenemia and specific IgM and IgG antibody responses in rabbits infected with Toxoplasma gondii.

Authors:  Juan Hua Quan; Hassan Ahmed Hassan; Guang-Ho Cha; Dae-Whan Shin; Young-Ha Lee
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

7.  Passive protection of suckling infant mice against F41-positive enterotoxigenic Escherichia coli strains by intravenous inoculation of the dams with monoclonal antibodies against F41.

Authors:  M Duchet-Suchaux; P Menanteau; F G van Zijderveld
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Authors:  Isabelle Dimier-Poisson; Fleur Aline; Marie-Noëlle Mévélec; Céline Beauvillain; Dominique Buzoni-Gatel; Daniel Bout
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 9.  Protein kinases of Toxoplasma gondii: functions and drug targets.

Authors:  Feng Wei; Wei Wang; Quan Liu
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

10.  The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis.

Authors:  Alaa Bassuny Ismael; Dalila Sekkai; Christine Collin; Daniel Bout; Marie-Noëlle Mévélec
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.